share_log
  • Headlines
  • xinjiang bai hua cun pharma tech (600721.SH): the net income in the first three quarters was 23.9532 million yuan, a year-on-year increase of 35.39%.

百花医药(600721.SH)：前三季度净利润2395.32万元，同比增长35.39%

xinjiang bai hua cun pharma tech (600721.SH): the net income in the first three quarters was 23.9532 million yuan, a year-on-year increase of 35.39%.

Gelonghui Finance ·  Oct 24, 2024 15:43

On October 24, Bai Hua Cun Pharma Tech (600721.SH) announced that the company's revenue for the first three quarters was 0.291 billion yuan, a year-on-year increase of 9.38%; the net income attributable to shareholders of the listed company was 23.9532 million yuan, a year-on-year increase of 35.39%; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 21.7014 million yuan, a year-on-year increase of 32.52%; and the basic earnings per share was 0.0627 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    PharmaResources
    301230
    -- 24.59
    GemPharmatech
    688046
    -- 13.89
    Chengdu Bright Eye Hospital Group
    301239
    -- 42.00
    Hitgen Inc.
    688222
    -- 12.12
    R&G PharmaStudies
    301333
    -- 47.11
    Log In for the Full List
    China Concept Stocks
    Tracking the US-listed Chinese companies.